It is found that high pretreatment expression of OSM is strongly associated with failure of anti-TNF therapy of patients with IBD, which revealed the role of the receptor (OSMR) as part of a unique pathway that contributes to the chronicity of intestinal inflammation (West et al., 2017). This evidence concerns the gene OSMR and inflammatory bowel disease.